GnRH Agonist at Embryo Transfer: IVF Outcomes

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 15, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2021

Conditions
InfertilityInfertility, FemaleInfertility, Male
Interventions
DRUG

Saline Solution for Injection

Placebo arm will receive a saline injection

DRUG

Leuprolide Acetate

Treatment arm will receive a Leuprolide injection

Trial Locations (1)

11204

Genesis Fertility Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER

NCT03544073 - GnRH Agonist at Embryo Transfer: IVF Outcomes | Biotech Hunter | Biotech Hunter